EDWARD G. TORRANCE, M.D.; TRUMAN G. SCHNABEL, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Sickle cell anemia is a disease of unknown etiology, its prognosis is uncertain and its treatment is entirely symptomatic. In its active stage it is noteworthy for its spontaneous remissions and relapses. Most observers have found that treatments thus far suggested do not materially alter the course of the disease. No therapeutic procedure seems to influence the degree of sickling in vivo. Blood transfusions bring about remissions with uncertain regularity, and are of temporary value when so induced. They do on occasions tide a severely anemic patient over a critical period.
Liver diet has been tried by Sydenstricker1 and others
TORRANCE EG, SCHNABEL TG. Potassium Sulphocyanate: A Note on Its Use for the Painful Crises in Sickle Cell Anemia. Ann Intern Med. ;6:782–788. doi: 10.7326/0003-4819-6-6-782
Download citation file:
Published: Ann Intern Med. 1932;6(6):782-788.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use